Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Liabilities and Shareholders Equity (2016 - 2025)

Cavitation Technologies' Liabilities and Shareholders Equity history spans 15 years, with the latest figure at $55000.0 for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 92.34% year-over-year to $55000.0; the TTM value through Dec 2025 reached $988000.0, down 25.04%, while the annual FY2025 figure was $297000.0, 19.76% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $55000.0 at Cavitation Technologies, down from $60000.0 in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.0 million in Q3 2021 and bottomed at $55000.0 in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $647000.0 (2024), against an average of $1.1 million.
  • The largest annual shift saw Liabilities and Shareholders Equity crashed 94.25% in 2023 before it skyrocketed 647.92% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.7 million in 2021, then plummeted by 37.93% to $1.7 million in 2022, then plummeted by 94.25% to $96000.0 in 2023, then surged by 647.92% to $718000.0 in 2024, then crashed by 92.34% to $55000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVAT's Liabilities and Shareholders Equity are $55000.0 (Q4 2025), $60000.0 (Q3 2025), and $297000.0 (Q2 2025).